277 related articles for article (PubMed ID: 31173518)
21. Peptide Amphiphile Micelles for Vaccine Delivery.
Barrett JC; Tirrell MV
Methods Mol Biol; 2018; 1798():277-292. PubMed ID: 29868967
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Immune Responses by Virus-Mimetic Polymeric Nanostructures Against Infectious Diseases.
Li X; Liu S; Yin P; Chen K
Front Immunol; 2021; 12():804416. PubMed ID: 35126367
[TBL] [Abstract][Full Text] [Related]
23. Intranasal Subunit Vaccination Strategies Employing Nanomaterials and Biomaterials.
Cossette B; Kelly SH; Collier JH
ACS Biomater Sci Eng; 2021 May; 7(5):1765-1779. PubMed ID: 33326740
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in the Use of Plant Virus-Like Particles as Vaccines.
Balke I; Zeltins A
Viruses; 2020 Feb; 12(3):. PubMed ID: 32121192
[TBL] [Abstract][Full Text] [Related]
25. Particle-based platforms for malaria vaccines.
Wu Y; Narum DL; Fleury S; Jennings G; Yadava A
Vaccine; 2015 Dec; 33(52):7518-24. PubMed ID: 26458803
[TBL] [Abstract][Full Text] [Related]
26. Epitope discovery and their use in peptide based vaccines.
Dudek NL; Perlmutter P; Aguilar MI; Croft NP; Purcell AW
Curr Pharm Des; 2010; 16(28):3149-57. PubMed ID: 20687873
[TBL] [Abstract][Full Text] [Related]
27. Harnessing self-assembled peptide nanoparticles in epitope vaccine design.
Negahdaripour M; Golkar N; Hajighahramani N; Kianpour S; Nezafat N; Ghasemi Y
Biotechnol Adv; 2017 Sep; 35(5):575-596. PubMed ID: 28522213
[TBL] [Abstract][Full Text] [Related]
28. Tailoring Biomaterials for Cancer Immunotherapy: Emerging Trends and Future Outlook.
Wang C; Ye Y; Hu Q; Bellotti A; Gu Z
Adv Mater; 2017 Aug; 29(29):. PubMed ID: 28556553
[TBL] [Abstract][Full Text] [Related]
29. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
[TBL] [Abstract][Full Text] [Related]
30. Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands.
Xu Z; Moyle PM
Bioconjug Chem; 2018 Mar; 29(3):572-586. PubMed ID: 28891637
[TBL] [Abstract][Full Text] [Related]
31. Immunomodulatory properties of chitosan polymers.
Moran HBT; Turley JL; Andersson M; Lavelle EC
Biomaterials; 2018 Nov; 184():1-9. PubMed ID: 30195140
[TBL] [Abstract][Full Text] [Related]
32. Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies.
Chianese-Bullock KA; Lewis ST; Sherman NE; Shannon JD; Slingluff CL
Vaccine; 2009 Mar; 27(11):1764-70. PubMed ID: 19185050
[TBL] [Abstract][Full Text] [Related]
33. Applications of chemokines as adjuvants for vaccine immunotherapy.
Mohan T; Zhu W; Wang Y; Wang BZ
Immunobiology; 2018; 223(6-7):477-485. PubMed ID: 29246401
[TBL] [Abstract][Full Text] [Related]
34. Immunocontraception: Filamentous Bacteriophage as a Platform for Vaccine Development.
Samoylova TI; Braden TD; Spencer JA; Bartol FF
Curr Med Chem; 2017 Nov; 24(35):3907-3920. PubMed ID: 28901276
[TBL] [Abstract][Full Text] [Related]
35. MHC class II allosteric site drugs: new immunotherapeutics for malignant, infectious and autoimmune diseases.
Xu M; Li J; Gulfo JV; Von Hofe E; Humphreys RE
Scand J Immunol; 2001; 54(1-2):39-44. PubMed ID: 11439146
[TBL] [Abstract][Full Text] [Related]
36. Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses.
Kumai T; Lee S; Cho HI; Sultan H; Kobayashi H; Harabuchi Y; Celis E
Cancer Immunol Res; 2017 Jan; 5(1):72-83. PubMed ID: 27941004
[TBL] [Abstract][Full Text] [Related]
37. Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications.
Wang CY; Walfield AM
Vaccine; 2005 Mar; 23(17-18):2049-56. PubMed ID: 15755569
[TBL] [Abstract][Full Text] [Related]
38. Peptidomimetics: modifying peptides in the pursuit of better vaccines.
Croft NP; Purcell AW
Expert Rev Vaccines; 2011 Feb; 10(2):211-26. PubMed ID: 21332270
[TBL] [Abstract][Full Text] [Related]
39. A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N; Ghasemi Y; Javadi G; Khoshnoud MJ; Omidinia E
J Theor Biol; 2014 May; 349():121-34. PubMed ID: 24512916
[TBL] [Abstract][Full Text] [Related]
40. Synthetic peptides as cancer vaccines.
Sundaram R; Dakappagari NK; Kaumaya PT
Biopolymers; 2002; 66(3):200-16. PubMed ID: 12385038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
